OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future

Name: OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future
SKU: 27386
Availability: InStock

$0.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 54 No. 4 Articles – 2024 Tags: adverse-effects, andrew-j-cutler, attention-deficit-disorder-with-hyperactivity, Craig Chepke, drug-development, Elizabeth Brunner, pharmacology, serotonin, serotonin agents

Description

Description

General Psychiatry

Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future

By Craig Chepke, Elizabeth Brunner, Andrew J. Cutler

OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future

Description

General Psychiatry

Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents

Divalproex and Epilepsy

Coping With Somatic Comorbidities: Striving for Complete Recovery

Induction of Psychosis by Cyclobenzaprine

OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future

Description

General Psychiatry

Related products

Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents

Divalproex and Epilepsy

Coping With Somatic Comorbidities: Striving for Complete Recovery

Induction of Psychosis by Cyclobenzaprine